David H. Sherman is the Hans W. Vahlteich Professor of Medicinal Chemistry at the University of Michigan, holding joint appointments in the College of Pharmacy (Department of Medicinal Chemistry), Medical School (Microbiology & Immunology), and College of Literature, Science, and the Arts (Chemistry). He leads the Sherman Lab at the Life Sciences Institute and co-founded the Natural Products Discovery Core. His research focuses on natural product discovery, biosynthetic pathways, and drug development for infectious diseases, cancer, and neurological disorders. Education: PhD in Synthetic Organic Chemistry from Columbia University (1981), BA in Chemistry from UC Santa Cruz (1978). Postdoctoral research at MIT (1984). Research interests include microbial secondary metabolites, enzymatic catalysis (e.g., C-H functionalization, polyketide assembly), and high-throughput drug screening. He pioneered a microbial natural product library with over 50,000 samples. Current projects emphasize developing macrolide antibiotics and advancing compounds toward clinical trials through the Natural Products Biosciences Initiative. Collaborations span global institutions, with a focus on biodiversity conservation and capacity-building in low-income nations. He has mentored 67 PhD students, 60 postdocs, and 85+ undergraduates, fostering interdisciplinary training in chemical biology and microbial biochemistry. Labs/Teams: Sherman Lab (Life Sciences Institute), Center Member at Samuel and Jean Frankel Cardiovascular Center, Center for Computational Medicine and Bioinformatics, Rogel Cancer Center.
J. Anthony Movshon is a Professor at New York University (NYU) in the Department of Psychology and a key member of NYU's Center for Neural Science (CNS). His research focuses on the primate visual system, particularly the encoding and decoding of visual information in cortical areas like V1 and MT, and its role in behavior and perception. Education: Doctorate in Visual Neurophysiology and Psychophysics from Cambridge University Research Interests: Movshon investigates the functional architecture of the visual cortex, emphasizing motion, form, and color processing. His work explores how neural activity relates to perceptual decisions and motor behavior, using electrophysiological recordings, neuroimaging, and computational models. He also studies developmental disorders like amblyopia and their impact on visual system organization. Publications: His recent work spans visual texture selectivity in V2, contextual modulation in neural responses, motion processing in MT, and decoding mechanisms in visual cortex. These studies employ interdisciplinary approaches blending neurophysiology, computational neuroscience, and cognitive modeling. Labs & Collaborations: Movshon leads the Visual Neuroscience Laboratory at NYU, collaborating with researchers such as Michael Hawken, Lynne Kiorpes, and Eero Simoncelli.
Anirban Paul is an Associate Professor in the Department of Neuroscience and Experimental Therapeutics at Pennsylvania State University, affiliated with the Penn State Neuroscience Institute. His research focuses on cellular and molecular mechanisms of GABAergic inhibitory circuits, with particular emphasis on interneuron biology and its implications in neurological disorders. Dr. Paul's research spans multiple neuroscience domains, with primary focus on GABAergic inhibitory circuits and interneuron biology. His work investigates how specific neuron subtypes, particularly Chandelier cells and cortical interneurons, contribute to brain function and dysfunction. He has made significant contributions to understanding the role of these cells in schizophrenia, Alzheimer's disease, and other neurological conditions. His research integrates molecular, cellular, and systems-level approaches to uncover fundamental mechanisms of neural circuit assembly, plasticity, and function. Key areas include RNA regulation in neuronal development, transcriptomic subtypes of inhibitory neurons, and cell-type specific vulnerabilities in neurodegenerative diseases. His research portfolio demonstrates consistent productivity with publications spanning from 2003 to 2025, showing an evolving focus from basic molecular neuroscience to translational research in neurological disorders. Recent work emphasizes single-cell analysis techniques and the role of specific interneuron populations in disease mechanisms, particularly in schizophrenia and Alzheimer's disease. His publications appear in high-impact neuroscience journals including Neuron, BMC Biology, and Frontiers in Cellular Neuroscience. Dr. Paul has received the NARSAD Young Investigator Award (2018), recognizing his promising research in neuroscience. His scientific contributions have been supported by multiple competitive grants from prestigious organizations including the National Institute on Aging (NIA) and the Brain and Behavior Research Foundation. He serves as Principal Investigator on multiple active research projects, including two major grants from the National Institute on Aging focused on cell-type specific risk and resilience in Alzheimer's disease and aging (2021-2024 and 2024-2026), as well as previous projects from the Brain and Behavior Research Foundation investigating Chandelier cells in schizophrenia. His research program demonstrates sustained funding and scientific leadership in the field of interneuron biology and its clinical implications.
Akbal Gill is a Clinical Fellow in the Department of Neurology at Yale School of Medicine. Their work intersects with various clinical programs including the Yale Headache and Facial Pain Center, Yale Concussion Program, and Neurocritical Care initiatives. As a member of the Neurology faculty, they contribute to resident education pathways such as the Clinician Educator Distinction and Global Neurology Distinction. The Neurology department at Yale encompasses diverse research areas like neuroimmunology, neuromuscular medicine, and experimental neuroimaging, with Gill's role likely involving collaboration across these domains.
Holly J. Benjamin, MD is a distinguished sports medicine specialist at the University of Chicago, serving as the inaugural Director of the Primary Care Sports Medicine Program at UChicago Medicine Student Wellness Center. She holds leadership positions including Chair of the Committee on Sports Medicine & Fitness for the Illinois Chapter of the American Academy of Pediatrics, and serves as Head Medical Team Physician for the WNBA Chicago Sky and medical officer for major events including the Bank of America Chicago Marathon, US Soccer, and USA Triathlon. Her educational background includes: B.S. in Integrated Life Sciences, Kent State University (1994) Combined BS/MD, Northeastern Ohio Universities College of Medicine (1994) MD, Northeastern Ohio Universities College of Medicine (1994) Residency in Pediatrics, The University of Chicago Children's Hospital (1997) Fellowship in Primary Care Sports Medicine, Lutheran General Hospital (1998) Dr. Benjamin specializes in sports medicine with particular expertise in youth, adolescent, and collegiate athletes. Her research spans acute and overuse sports injuries, concussion management, sport biomechanics, and musculoskeletal ultrasound. She has made significant contributions to understanding injury prevention strategies, safe return-to-play protocols, and the psychological aspects of sports injuries. Her work frequently addresses female athletes and elite/professional athletes, with emphasis on evidence-based approaches to optimize performance while minimizing injury risk. Recent publications demonstrate a strong focus on concussion research, with multiple studies examining diagnostic approaches, recovery trajectories, and factors influencing outcomes. Her work spans biomechanics, mental health considerations in sports injuries, and innovative approaches to injury prevention across various athletic populations. Her scientific recognition includes: Election as Fellow of the American College of Sports Medicine (2003), becoming the second female pediatrician ever elected Election as Fellow of the American Medical Society of Sports Medicine Distinguished Alumni Award from The New Aurora High School Alumni (1999) Invitation to serve as volunteer physician for the Olympic Training Center (2008) Multiple expert contributions to national media including Runner's World and the Naperville Sun Dr. Benjamin actively mentors through her coaching roles at high school and collegiate levels, emphasizing safe return-to-play post-injury and injury prevention. She has developed educational content through video productions for the American Academy of Pediatrics and serves as head team physician for the University of Chicago Lab School and the NCAA Division III UChicago Maroons. Notably, she is one of only a few sports medicine specialists in the country offering diagnostic and procedural musculoskeletal ultrasound in her office, demonstrating her commitment to advanced diagnostic capabilities for patient care.
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.
Lily Pham is an Assistant Professor of Neurology at the University of Maryland School of Medicine, specializing in neuro-oncology. She treats primary brain cancers and neurological complications of cancer. Education: Duke University (2012), Virginia Tech Carilion School of Medicine (2016) Training: Neurology residency at Baylor College of Medicine (2020), Neuro-Oncology fellowship at MD Anderson Cancer Center (2022) Her research focuses on clinical trial development for novel brain tumor therapies, particularly targeted treatments for high-grade glioma and meningioma. She combines clinical practice with chemotherapy prescription and intrathecal delivery techniques.
Cristian Gómez Canela is a Full Professor in the Department of Analytical and Applied Chemistry at the School of Engineering, Ramon Llull University (IQS). He serves as Coordinator of the Master's Degree in Analytical Chemistry and is an active member of the Catalan Chemical Society (SCQ), representing SCQ in EuChems-EYCN. His academic journey includes a PhD in Chemistry from the University of Barcelona (2014), followed by postdoctoral research at IDAEA-CSIC and King's College University. Dr. Gómez Canela's research focuses on environmental analytical chemistry, particularly the optimization and validation of analytical methods based on liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and high-resolution mass spectrometry (HRMS) for determining organic pollutants in environmental samples. His work extends to metabolomics applied to aquatic organisms and the analysis of neurotoxic compounds in water systems. His research fingerprint reveals strong expertise in zebrafish models (100%), neurotransmitter analysis (66%), Daphnia magna studies (64%), and neurotoxicity assessment (21%). His recent publications (2024-2025) demonstrate a clear trend toward environmental neurotoxicology, with emphasis on the effects of pharmaceuticals and industrial pollutants on aquatic organisms. His work integrates advanced analytical techniques with biological endpoints to assess environmental risks, particularly focusing on neurological and cardiovascular impacts. The research spans method development for pollutant detection, environmental monitoring, and mechanistic studies of neurotoxic effects. Dr. Gómez Canela leads multiple significant research projects including CHEMIPARK (2024-2027) on passive sampling methodologies for environmental pollutants, GESPA (2022-2025) as part of the Environmental Process Engineering and Simulation Group, and several projects on neuroactive compounds in water systems. He has an impressive research output with 91 scientific publications from 2011-2025 and an h-index of 27 with over 2,000 citations. As a dedicated educator, he contributes to multiple academic programs including the Master in Analytical Chemistry, Master in Pharmaceutical Chemistry, and undergraduate degrees in Chemistry and Chemical Engineering. His research group GESPA represents a multidisciplinary team combining chemical engineering, biotechnology, and chemical analysis to advance environmental sustainability through theoretical and experimental approaches.
Marc V Fuccillo is an Associate Professor of Neuroscience at the Perelman School of Medicine, University of Pennsylvania, where he leads a research laboratory focused on understanding the neural circuit mechanisms underlying behavioral control. His work bridges molecular, synaptic, and behavioral approaches to investigate how striatal circuits regulate mouse behavior from simple motor patterns to complex goal-directed actions. Fuccillo holds dual appointments in the Neuroscience and Cell and Molecular Biology Graduate Groups at Penn and maintains an active laboratory investigating the synaptic and circuit basis of neuropsychiatric disorders. Education: B.A. in Molecular and Cellular Biology and Music Performance (Violin) from Brown University (1998) Ph.D. in Developmental Genetics from New York University School of Medicine (2007) M.D. from New York University School of Medicine (2008) Fuccillo's research centers on the synaptic and circuit mechanisms of behavioral control, with particular emphasis on striatal circuits. His laboratory employs a range of technologies including mouse genetics, in vitro electrophysiology, in vivo imaging, and quantitative behavioral analysis to explore how neural circuits of the striatum regulate behavior and how disruptions in these circuits contribute to neuropsychiatric disorders. His work has particularly focused on autism-associated abnormalities in behavioral control, examining how synaptic adhesion molecules like neuroligins and neurexins shape circuit function and behavior, with significant findings regarding D1 dopamine receptor positive medium spiny neurons in the nucleus accumbens. Analysis of Fuccillo's recent publications reveals a strong focus on striatal circuit function across multiple dimensions. His work spans molecular neuroscience (examining synaptic adhesion molecules), cellular physiology (studying specific neuron types in striatal circuits), systems neuroscience (mapping circuit connectivity), and behavioral neuroscience (quantifying motor learning and decision-making). A unifying theme is how disruptions in specific molecular pathways lead to circuit-level abnormalities that manifest as behavioral phenotypes relevant to neuropsychiatric disorders, with particular attention to autism, OCD, and schizophrenia models. Scientific Recognition: Publications in high-impact journals including Nature Neuroscience, Current Biology, Cell Reports, and Neuron Research supported by multiple NIH grants including NIMH F32, NIMH K01, and HHMI Gilliam Fellowship awards for lab members Fuccillo actively mentors a diverse group of trainees including postdoctoral fellows, graduate students, and undergraduates. His laboratory has produced numerous successful alumni who have gone on to faculty positions, medical residencies, and graduate programs at prestigious institutions. His mentoring approach emphasizes technical skill development across multiple neuroscience disciplines while fostering independent scientific thinking. Current research in his lab is supported by NIH funding focused on understanding the molecular architecture of striatal circuits and their role in behavioral control, with three major research directions exploring molecular logic of striatal circuits, circuit mechanisms of behavioral control, and striatal dysfunction in neuropsychiatric disease models. The Fuccillo Laboratory operates within the Department of Neuroscience at the University of Pennsylvania, with access to state-of-the-art facilities for molecular, electrophysiological, imaging, and behavioral neuroscience research. The lab maintains active collaborations with other neuroscience research groups at Penn and beyond, creating a rich intellectual environment for studying the neural basis of behavior. Current research directions include investigating whether there is a molecular logic to striatal circuit composition, how striatal circuits shape behavioral control, and what mouse models of autism, schizophrenia, and OCD can reveal about striatal circuit dysfunction in disease pathophysiology.
University of California, Los AngelesUnited States
Dr. Steven G. Clarke is a Distinguished Professor at UCLA Department of Chemistry & Biochemistry and director of research at the Molecular Biology Institute . His work bridges protein chemistry , methylation biology , and aging research through studies of spontaneous protein damage and its repair mechanisms. Education: BA in Chemistry and Zoology, Pomona College (magna cum laude, Phi Beta Kappa) PhD in Biochemistry and Molecular Biology, Harvard University (NSF Fellow) Postdoctoral Fellowship at UC Berkeley (Miller Fellow) Dr. Clarke's research focuses on protein isoaspartyl repair via PCMT1/PIMT enzymes , ribosomal protein methylation in Saccharomyces cerevisiae , and PRMT family characterization including PRMT7 and PRMT9. His lab combines biochemical assays , genetic models , and structural analysis to investigate aging mechanisms and disease implications. Recent publications highlight: COQ5 structure-function analysis in coenzyme Q biosynthesis PCMTD1 ubiquitin ligase interactions PRMT7 substrate specificity in histone H2B Protein isoaspartyl impacts on T cell function in lupus Novel PRMT inhibitors for cancer therapy Methionine addiction in osteosarcoma malignancy Major scientific awards: American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry NIH MERIT Award Ellison Medical Foundation Senior Scholar Award William C. Rose Award, ASBMB UCLA Distinguished Teaching Award (Eby Award winner) Current lab members include PhD candidates Eric Pang (UCSB) and Sining "Cindy" Wang (UCLA), while undergraduates Celeste Medina-Seymoure , Elizabeth Oroudjeva , Olivia Pacheco , and Jasmine Winter contribute to ongoing proteostasis studies. Collaborations with Profs. Jose Rodriguez and Catherine Clarke demonstrate interdisciplinary research approaches.
University of North Carolina at Chapel HillUnited States
Tanya P. Garcia, PhD is an Associate Professor of Biostatistics at the Gillings School of Public Health and Research Faculty in the UNC Neurology Huntington Disease Program at the University of North Carolina at Chapel Hill . She leads the Methods for INcomplete Data (MIND) Lab , focusing on statistical methods for handling censored, missing, or incomplete data in neurodegenerative disease progression studies. Education: PhD in Statistics, Texas A&M University MS in Statistics, University of Western Ohio MS in Industrial Engineering and Operations Research, UC Berkeley Research Interests: Specializing in High-Dimensional Variable Selection , Longitudinal Data Analysis , and Neurodegenerative Disease Modeling , her work develops reproducible statistical methods for Huntington's disease progression, improving clinical trial design and biomarker identification. Scientific Awards: American Statistical Association Fellow (2024) Landis Award for Outstanding Mentorship (2024) Roy R. Kuebler Award (2024) Gertrude M. Cox Award (2024) Leadership & Mentorship: Director of the MIND Lab, Chair-Elect of the Biometrics Section of ASA, and Tyson Academic Leadership Fellow (2023–2024). Her lab alumni have secured prestigious positions at institutions like Wake Forest University and Baylor University.
Takako Fujioka is an Associate Professor of Music at Stanford University, affiliated with the Center for Computer Research in Music and Acoustics (CCRMA). Her research focuses on the neural mechanisms underlying auditory perception, auditory-motor coupling, and music-supported therapy for neurorehabilitation. She holds a Ph.D. in Physiology from the Graduate University for Advanced Studies, Japan, and M.Sc./B.Eng. degrees in Electrical Engineering from Waseda University. Her work combines neurophysiological techniques such as MEG and EEG to study brain plasticity in development, aging, and stroke recovery. Notable contributions include investigating how music influences motor and cognitive recovery in stroke patients, as well as exploring the neural basis of musical perception through rhythmic synchronization and pitch discrimination studies. Supported by awards from the Canadian Institutes of Health Research during her postdoctoral work at the Rotman Research Institute, her research bridges clinical neuroscience and music cognition. Dr. Fujioka’s expertise spans auditory neuroscience, neurorehabilitation, and technology-assisted music therapy. She has pioneered studies on tactile mapping for cochlear implant users and networked music performance systems, emphasizing cross-modal perception and human-technology interaction. Her findings contribute to both theoretical understanding of auditory processing and practical applications in medical and educational settings. Awards: Canadian Institutes of Health Research Awards (postdoctoral phase) Labs/Teams: CCRMA, Stanford Music Perception Laboratory, Rotman Research Institute collaborations Key Themes: Neuroplasticity, Music-Mediated Rehabilitation, Auditory-Motor Integration, Multisensory Processing Her recent work examines aging-related changes in binaural hearing and the role of beta/gamma oscillations in rhythmic processing. She advocates for translational research that connects neural mechanisms with real-world therapeutic interventions.
Cara Lena Crook, PhD, is an Assistant Professor in the Department of Neurology at Yale School of Medicine. She specializes in neuropsychology, focusing on how brain function affects cognition, emotion, and behavior in patients with neurological and psychological conditions. Institution: Yale School of Medicine Department: Neurology Academic Rank: Assistant Professor Dr. Crook earned her PhD in Clinical Neuropsychology from Fordham University, completed her residency at Alpert Medical School of Brown University, and a fellowship at VA Boston Healthcare System, where she advanced her skills in neuropsychological assessment and intervention. Her research and clinical interests center on understanding the neural basis of cognitive and emotional processes. She works at the intersection of neurology and psychology, contributing to patient care, teaching, and scholarly activity in clinical neuropsychology. Though specific publications are not listed, her work likely spans assessment methodologies, cognitive disorders, and brain-behavior relationships in neurological populations. Dr. Crook is actively engaged in the academic and clinical missions at Yale, with no indication of part-time status or retirement. She is not noted as a former staff member and is currently contributing to the department’s educational and research initiatives. PhD: Fordham University, Clinical Neuropsychology (2022) Residency: Alpert Medical School of Brown University, Neuropsychology (2022) Fellowship: VA Boston Healthcare System (2024) She has not been cited as having formal advisees or receiving specific scientific awards in the available text. There is no mention of grants, labs, or research teams she leads, though her fellowship and academic appointments suggest active involvement in clinical research and training.
Virginia Polytechnic Institute and State UniversityUnited States
Martha Ann Bell is a University Distinguished Professor of Psychology and College of Science Faculty Fellow at Virginia Tech. She leads the Cognition, Affect, and Psychophysiology (CAP) Lab, focusing on developmental cognitive neuroscience and the integration of emotion and cognition in early development. Her work examines EEG/ECG biomarkers, executive function, temperament, and maternal-child interactions. Dr. Bell holds a PhD in Human Development from the University of Maryland (1992), an MS in Child and Family Studies from the University of Tennessee (1983), and a BS in Home Economics from Carson-Newman College (1978). She has held progressive roles from Assistant Professor (1996) to her current distinguished title. Her research interests include developmental changes in brain-behavior relations, neurophysiological correlates of emotion regulation, and longitudinal predictors of child development. Recent work explores maternal emotion coaching, EEG neuromarkers of ADHD, and the neurodevelopmental impacts of nutrition. Key awards include the Virginia Tech University Distinguished Professorship (2021) and College of Science Faculty Fellowship (2019–2025). Her publications span developmental psychobiology, neuroimaging methods, and temperament-behavior links. Dr. Bell’s advising and grants focus on interdisciplinary developmental science. The CAP Lab collaborates on projects involving infant neuroimaging, maternal-child physiology, and early childhood interventions.
